AMRX — Amneal Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $6.70bn
- $9.39bn
- $3.02bn
Focus: Patients scramble to find estrogen patches as shortage worsens after US FDA champions use
US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings
Amneal Pharmaceuticals Q4 revenue slightly beats on Specialty segment strength
Brief: Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing
Brief: Amneal Pharma To Settle Majority Of Opioids-Related Claims
U.S. STOCKS ON THE MOVE-Amneal Pharma, Ardelyx, Snap
Amneal Pharma gains as co poised to join S&P SmallCap index
Brief: Amneal Pharma Expects To Meet Or Exceed Its 2025 Full-Year Financial Guidance
Brief: KeifeRX Announces Research Collaboration & Option Agreement With Amneal Pharmaceuticals
Brief: Amneal Receives U.S. FDA Approval For Epinephrine Injection
Brief: Amneal Announces Positive Interim Phase 4 Elevate-Pd Results With Crexont For Parkinson’S Disease
AT&T sues generic drugmakers over alleged price-fixing scheme
U.S. STOCKS ON THE MOVE-CrowdStrike Holdings, Procter & Gamble, Ford Motor
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Cloudflare, Boeing
U.S. STOCKS ON THE MOVE-Janux Therapeutics, Bunge Global, Shopify
Brief: Amneal Receives U.S. FDA Approval For Albuterol Sulfate Inhalation Aerosol
Amneal rises after US FDA nod for generic asthma inhaler
Brief: Amneal Receives U.S. FDA Approval For Iohexol Injection
U.S. RESEARCH ROUNDUP- Amazon, Apple, Cigna